NCT05954351已完成不适用
PRactice of Ventilation and Adjunctive Therapies in COVID-19 Patients; What is the Optimal Ventilation Strategy in Critically Ill COVID-19 Patients, in Particular PEEP and the Moment of Switch to Pressure Support?
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 个研究点 分布在 1 个国家目标入组 2,465 人开始时间: 2022年5月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,465
- 试验地点
- 1
- 主要终点
- ICU mortality
研究概览
简要总结
PRactice of Ventilation and Adjunctive Therapies in COVID-19 Patients. An observational study of ventilation practice and adjunctive therapies in critically ill, invasively ventilated COVID-19 patients during the first and second surge of COVID-19 in the Netherlands.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 120 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •receiving invasive ventilation or high-flow nasal oxygen for COVID-19 for SARS-CoV-2
- •admitted to one of the ICUs of the participating hospitals
排除标准
- 未提供
结局指标
主要结局
ICU mortality
时间窗: 90 days from inclusion
次要结局
- 28-day ventilator free days(90 days from inclusion)
- Duration of ventilation(90 days from inclusion)
- 28-day, 90-day mortality(90 days from inclusion)
- ICU and hospital length of stay(90 days from inclusion)
研究者
Prof. Dr. Marcus J. Schultz
Professor Dr. Marcus J. Schultz
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
研究点 (1)
Loading locations...
相似试验
已完成
不适用
PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID)COVIDMechanical VentilationAcute Respiratory FailureNCT04346342Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1,122
Unknown
不适用
Adaptive Support Ventilation in Acute Respiratory Distress Syndrome (ARDS)Respiration, ArtificialRespiratory Distress Syndrome, AdultNCT01165528Post Graduate Institute of Medical Education and Research, Chandigarh40
已完成
不适用
Non-invasive Ventilatory Support of Patients Affected by COVID-19Covid-19NCT04382235University of Milano Bicocca909
Unknown
2 期
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory DistressCovid19NCT04905836Sorrento Therapeutics, Inc.60
终止
不适用
AnaConDa-therapy in COVID-19 PatientsCOVID-19SARS CoV-2NCT05586126Jeroen Bosch Ziekenhuis42